Greenway Greenhouse Cannabis Corporation (CSE:GWAY)
Canada · Delayed Price · Currency is CAD 0.0900
-0.0100 (-10.00%)
Sep 18, 2026, 12:08 PM EST
CSE:GWAY Income Statement
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 8.06 | 7.45 | 8.95 | 5.23 | 5.62 | 1.98 | |
Revenue Growth | -1.41% | -16.76% | 71.10% | -6.97% | 183.32% | - |
Cost of Revenue | 6.38 | 5.39 | 5.59 | 4.3 | 4.03 | 0.97 |
Gross Profit | 1.68 | 2.06 | 3.36 | 0.93 | 1.6 | 1.02 |
Selling, General & Admin | 2.13 | 2.19 | 2.12 | 1.75 | 1.86 | 1.39 |
Research & Development | 0.05 | 0.02 | 0.07 | - | - | 0.05 |
Amortization of Goodwill & Intangibles | 1.43 | 1.3 | 2.1 | 1.67 | 1.09 | 0.71 |
Operating Expenses | 3.61 | 3.51 | 4.28 | 4.42 | 3.65 | 3.15 |
Operating Income | -1.93 | -1.45 | -0.92 | -3.49 | -2.05 | -2.13 |
Interest Expense | -1.23 | -1.23 | -1.15 | -0.84 | -0.88 | -0.85 |
Interest & Investment Income | 0.03 | 0.03 | 0.06 | - | - | - |
Other Non Operating Income (Expenses) | 0.08 | 0.08 | - | -0.39 | 0.14 | 0.06 |
EBT Excluding Unusual Items | -3.06 | -2.56 | -2.02 | -4.72 | -2.8 | -2.92 |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.19 | - |
Asset Writedown | - | - | -0.04 | - | - | - |
Pretax Income | -3.06 | -2.56 | -2.06 | -4.72 | -2.61 | -2.92 |
Net Income | -3.06 | -2.56 | -2.06 | -4.72 | -2.61 | -2.92 |
Net Income to Common | -3.06 | -2.56 | -2.06 | -4.72 | -2.61 | -2.92 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 133 | 133 | 132 | 131 | 131 | 130 |
Shares Outstanding (Diluted) | 133 | 133 | 132 | 131 | 131 | 130 |
Shares Change | 0.83% | 0.71% | 0.15% | 0.34% | 0.78% | -22.35% |
EPS (Basic) | -0.02 | -0.02 | -0.02 | -0.04 | -0.02 | -0.02 |
EPS (Diluted) | -0.02 | -0.02 | -0.02 | -0.04 | -0.02 | -0.02 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -1.06 | -2.01 | 1.61 | -4.96 | -5.23 | -4.1 |
Free Cash Flow Per Share | -0.01 | -0.01 | 0.01 | -0.04 | -0.04 | -0.03 |
Gross Margin | 20.87% | 27.71% | 37.52% | 17.75% | 28.38% | 51.37% |
Operating Margin | -23.90% | -19.41% | -10.31% | -66.71% | -36.51% | -107.40% |
Profit Margin | -37.91% | -34.40% | -22.99% | -90.30% | -46.35% | -147.30% |
Free Cash Flow Margin | -13.13% | -26.93% | 18.01% | -94.92% | -93.11% | -206.37% |
EBITDA | -0.71 | -0.09 | 0.42 | -2.35 | -1.29 | -1.73 |
EBITDA Margin | -8.78% | -1.27% | 4.72% | -44.94% | -22.93% | -87.08% |
D&A For EBITDA | 1.22 | 1.35 | 1.35 | 1.14 | 0.76 | 0.4 |
EBIT | -1.93 | -1.45 | -0.92 | -3.49 | -2.05 | -2.13 |
EBIT Margin | -23.90% | -19.41% | -10.31% | -66.71% | -36.51% | -107.40% |
Revenue as Reported | 8.06 | 7.45 | 8.95 | 5.23 | 5.62 | - |